Requirement of Interleukin‐17A for Systemic Anti– Candida albicans Host Defense in Mice
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
T cells are required for normal host defense against fungal infection, and individuals with T cell-deficiency syndromes are highly susceptible to fungal pathogens. Interleukin (IL)-17A is a proinflammatory cytokine that interconnects myeloid and lymphoid host defense. The role of murine (m) IL-17A/mIL-17A receptor (R) interactions was evaluated in a murine model of systemic candidiasis. In response to systemic challenge with Candida albicans, expression of mIL-17A was induced, and IL-17AR knockout (IL-17AR(-/-)) mice had dose-dependent, substantially reduced survival. Fungal burden in the kidneys of IL-17AR(-/-) mice was dramatically increased (25-fold at 96 h). In IL-17AR(-/-) mice, both mobilization of peripheral neutrophils and their influx to infected organs were significantly impaired and delayed. In vivo expression of mIL-17A protected normal mice from a lethal dose of C. albicans (100% at day 7 and 65% at day 42). The data suggest that the mIL-17A/mIL-17AR system is required for normal fungal host defense in vivo. IL-17A could have potential as a therapeutic cytokine for systemic C. albicans infections in immunocompromised patients with cancer or advanced acquired immunodeficiency syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Confirming previous reports, IL-17RA-/- mice demonstrated significantly increased kidney fungal burden in comparison to WT following infection with C. albicans (CAF2-1 or SC5314) (Fig 1A) [14,16,33].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“IL-17RA-/-, IL-17RC-/-, RORγt-/- and IL-17A-/- mice are all susceptible to systemic C. albicans infection [14–17].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“During candidiasis, IL-17 is rapidly upregulated in the kidney, but its function in that organ is unknown [14].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“IL-17 is a key mediator of defense against candidiasis.”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“In recent years, considerable data have implicated IL-17 in immunity against disseminated candidiasis [14–16].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521
Self-citationTrends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997
McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., & Warnock, D. W. (2001) · Clinical Infectious Diseases · doi:10.1086/322606 · Cited by 657 · cited 1×
“suppressive cancer chemotherapy, especially if this treatment is followed by prolonged periods of neutropenia, such as seen in bone marrow transplantation [1, 2].”
BackgroundIL-17: prototype member of an emerging cytokine family
Aggarwal, S., & Gurney, A. L. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.1 · Cited by 597 · cited 1×
“tem, because of its unique effects [14].”
Interleukin-17 and Lung Host Defense against Klebsiella pneumoniae Infection
Ye, P., Garvey, P. B., Zhang, P., Nelson, S., Bagby, G., Summer, W. R., Schwarzenberger, P., Shellito, J. E., & Kolls, J. K. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.3.4424 · Cited by 461 · cited 2×
“Although statistically significant, this finding was less pronounced than that observed in our previous studies of gram-negative bacteria challenge, in which IL17AR / mice failed entirely to mount a peripheral neutrophil response [8, 9].”
ResultSelf-citationSchwarzenberger, P., La Russa, V., Miller, A., Ye, P., Huang, W., Zieske, A., Nelson, S., Bagby, G. J., Stoltz, D., Mynatt, R. L., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6383 · Cited by 325 · cited 5×
“neutrophils and their precursors [7, 9] (data not shown).”
BackgroundMethodInfluentialSelf-citationAntibody response that protects against disseminated candidiasis
Han, Y., & Cutler, J. E. (1995) · Infection and Immunity · doi:10.1128/iai.63.7.2714-2719.1995 · Cited by 308 · cited 1×
“teractions between T cells and phagocytes and have reported that this phenomenon directly augments fungicidal properties [21-24].”
BackgroundCAUSES OF DEATH IN ADULTS WITH ACUTE LEUKEMIA
CHANG, H.-Y., RODRIGUEZ, V., NARBONI, G., BODEY, G. P., LUNA, M. A., & FREIREICH, E. J. (1976) · Medicine · doi:10.1097/00005792-197605000-00005 · Cited by 301 · cited 2×
“individuals [1, 5].”
Schwarzenberger, P., Huang, W., Ye, P., Oliver, P., Manuel, M., Zhang, Z., Bagby, G., Nelson, S., & Kolls, J. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4783 · Cited by 277 · cited 1×
“mIL-17A was found to exert significant effects on neutrophils and its precursors, not directly, but, to a large extent, via the induction and release of secondary or downstream cytokines from stromal cells [7, 15].”
BackgroundSelf-citationInfectious Complications of Chronic Lymphocytic Leukemia
WADHWA, P., & MORRISON, V (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.12.013 · Cited by 276 · cited 1×
“related to clinical outcomes [5, 6].”
Bacteremia and Fungemia in Patients with the Acquired Immunodeficiency Syndrome
WHIMBEY, E., GOLD, J. W. M., POLSKY, B., DRYJANSKI, J., HAWKINS, C., BLEVINS, A., BRANNON, P., KIEHN, T. E., BROWN, A. E., & ARMSTRONG, D. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-511 · Cited by 239 · cited 3×
“The data are encouraging for pursuing further development of mIL-17A in fungal infections, which could benefit immunocompromised individuals, especially patients with cancer or AIDS.”
Background
Cited by
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
“Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.”
BackgroundInfluentialRegulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101312 · Cited by 1,925
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
Ouyang, W., Kolls, J. K., & Zheng, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.004 · Cited by 1,700
“IL-17RA-deficient mice are also susceptible to Toxoplasmosis gondii (Kelly et al., 2005) and Candida albicans infection (Huang et al., 2004).”
Targeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Interleukin-17 and Type 17 Helper T Cells
Miossec, P., Korn, T., & Kuchroo, V. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0707449 · Cited by 1,409
Induction and effector functions of TH17 cells
Bettelli, E., Korn, T., Oukka, M., & Kuchroo, V. K. (2008) · Nature · doi:10.1038/nature07036 · Cited by 1,216
LeibundGut-Landmann, S., Groß, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1460 · Cited by 1,191
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia
Aujla, S. J., Chan, Y. R., Zheng, M., Fei, M., Askew, D. J., Pociask, D. A., Reinhart, T. A., McAllister, F., Edeal, J., Gaus, K., et al. (2008) · Nature Medicine · doi:10.1038/nm1710 · Cited by 1,171
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y., Spalding, C., Elloumi, H. Z., Paulson, M. L., et al. (2008) · Nature · doi:10.1038/nature06764 · Cited by 1,157
The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
Di Cesare, A., Di Meglio, P., & Nestle, F. O. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.59 · Cited by 1,129
“IL-17R-deficient mice are highly susceptible to infection by the Gram-negative bacterium, Klebsiella pneumoniae, and the fungus, Candida albicans (Ye et al., 2001; Huang et al., 2004).”
BackgroundTesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081463 · Cited by 1,024
IL-17 and IL-17-producing cells in protection versus pathology
Mills, K. H. G. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00746-9 · Cited by 1,000
An integrated model of the recognition of Candida albicans by the innate immune system
Netea, M. G., Brown, G. D., Kullberg, B. J., & Gow, N. A. R. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1815 · Cited by 946
Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
Lin, A. M., Rubin, C. J., Khandpur, R., Wang, J. Y., Riblett, M., Yalavarthi, S., Villanueva, E. C., Shah, P., Kaplan, M. J., & Bruce, A. T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100123 · Cited by 906
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
Martin, B., Hirota, K., Cua, D. J., Stockinger, B., & Veldhoen, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.020 · Cited by 822
“…in peripheral tissues for pathogen clearance (Forlow et al., 2001; Ye et al., 2001b) and host defense against Klebsiella or Candida infections (Huang et al., 2004; Ye et al., 2001a), and it can also protect mucosal barrier functions by stimulating tight junction formation and mucin secretion…”
BackgroundResultA Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
Glocker, E.-O., Hennigs, A., Nabavi, M., Schäffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810719 · Cited by 800
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
Kastelein, R. A., Hunter, C. A., & Cua, D. J. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104758 · Cited by 763
“A few infection models have shown a significant role for the IL-23/IL-17 axis, including Klebsiella infection in the lung (39), intravenous Candida albicans infection (40), and infection of the natural rodent pathogen Citrobacter”
BackgroundSaijo, S., Ikeda, S., Yamabe, K., Kakuta, S., Ishigame, H., Akitsu, A., Fujikado, N., Kusaka, T., Kubo, S., Chung, S.-H., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.001 · Cited by 733
“albicans has been suggested with IL-17RA-deficient mice and also IL-23p19-deficient mice (Conti et al., 2009; Huang et al., 2004).”
BackgroundDifferentiation and function of Th17 T cells
Stockinger, B., & Veldhoen, M. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.04.005 · Cited by 721
Th17 Cell Differentiation: The Long and Winding Road
McGeachy, M. J., & Cua, D. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.001 · Cited by 701
β‐glucan recognition by the innate immune system
Goodridge, H. S., Wolf, A. J., & Underhill, D. M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00793.x · Cited by 688
“(90) observed that C57BL ⁄6 mice deficient in IL-17A were significantly more susceptible to systemic C.”
BackgroundTh17: the third member of the effector T cell trilogy
Bettelli, E., Korn, T., & Kuchroo, V. K. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.07.020 · Cited by 652
Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3
Ma, C. S., Chew, G. Y. J., Simpson, N., Priyadarshi, A., Wong, M., Grimbacher, B., Fulcher, D. A., Tangye, S. G., & Cook, M. C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080218 · Cited by 652
Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections
Brenchley, J. M., Paiardini, M., Knox, K. S., Asher, A. I., Cervasi, B., Asher, T. E., Scheinberg, P., Price, D. A., Hage, C. A., Kholi, L. M., et al. (2008) · Blood · doi:10.1182/blood-2008-05-159301 · Cited by 648
Immune defence against Candida fungal infections
Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Kullberg, B.-J., & van de Veerdonk, F. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3897 · Cited by 642
IL-17 family: Cytokines, receptors and signaling
Gu, C., Wu, L., & Li, X. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.022 · Cited by 595
“These include Salmonella enterica [72], Streptococcus pneumoniae [73], Listeria monocytogenes [25, 74],Staphylococcus aureus [16, 75], Helicobacter pylori [76], Citrobacter rondentium [16], herpes simplex virus [77],Trypanosoma cruzi [78, 79] and Candida albicans [15, 80].”
BackgroundMease, P. J., van der Heijde, D., Ritchlin, C. T., Okada, M., Cuchacovich, R. S., Shuler, C. L., Lin, C.-Y., Braun, D. K., Lee, C. H., & Gladman, D. D. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209709 · Cited by 580
IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
Ben-Sasson, S. Z., Hu-Li, J., Quiel, J., Cauchetaux, S., Ratner, M., Shapira, I., Dinarello, C. A., & Paul, W. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902745106 · Cited by 568
“Th17 cells have been implicated in protective responses to extracellular bacteria (10, 11), to Toxoplasma gondii (12) and to fungi (13); protective immunity in mice vaccinated with antigens from M.”
BackgroundInterleukin-17 is a negative regulator of established allergic asthma
Schnyder-Candrian, S., Togbe, D., Couillin, I., Mercier, I., Brombacher, F., Quesniaux, V., Fossiez, F., Ryffel, B., & Schnyder, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061401 · Cited by 564
IL‐23 and the Th17 pathway promote inflammation and impair antifungal immune resistance
Zelante, T., De Luca, A., Bonifazi, P., Montagnoli, C., Bozza, S., Moretti, S., Belladonna, M. L., Vacca, C., Conte, C., Mosci, P., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737409 · Cited by 555
Umemura, M., Yahagi, A., Hamada, S., Begum, M. D., Watanabe, H., Kawakami, K., Suda, T., Sudo, K., Nakae, S., Iwakura, Y., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3786 · Cited by 519
“against Klebsiella or Candida infections (19, 20), rheumatoid ar-”
BackgroundThe Role of IL-17 and related cytokines in inflammatory autoimmune diseases
Kuwabara, T., Ishikawa, F., Kondo, M., & Kakiuchi, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/3908061 · Cited by 519
The roles of IL‐17A in inflammatory immune responses and host defense against pathogens
Iwakura, Y., Nakae, S., Saijo, S., & Ishigame, H. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00699.x · Cited by 513
“albicans infection (257), both IL-17A and IL-23 impair the antifungal activities of neutrophils by negatively regulating IFN-g-mediated induction of indoleamine 2,3-dioxygenase (261, 262), which has potent”
BackgroundInterleukin‐17 in host defence against bacterial, mycobacterial and fungal pathogens
Curtis, M. M., & Way, S. S. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.03017.x · Cited by 502
Microbial Translocation Across the GI Tract
Brenchley, J. M., & Douek, D. C. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075001 · Cited by 496
Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization
Lu, Y.-J., Gross, J., Bogaert, D., Finn, A., Bagrade, L., Zhang, Q., Kolls, J. K., Srivastava, A., Lundgren, A., Forte, S., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000159 · Cited by 493
“IL-17A signaling been shown to participate in host defense against extracellular pathogens, such as Klebsiella and Candida in naı̈ve mice [43,44].”
BackgroundThe Immunobiology of the Interleukin-12 Family: Room for Discovery
Tait Wojno, E. D., Hunter, C. A., & Stumhofer, J. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.011 · Cited by 482
“We now appreciate that the IL-23 and IL-17 axis is critical for protection against challenge with a number of extracellular pathogens, including Klebsiella, S. aureus, C. albicans, P. carinii, and C. rodentium (Cho et al., 2010; Happel et al., 2005; Huang et al., 2004; Mangan et al., 2006).”
BackgroundKhader, S. A., Gaffen, S. L., & Kolls, J. K. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.100 · Cited by 481
Interleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475
The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
Martin, D. A., Towne, J. E., Kricorian, G., Klekotka, P., Gudjonsson, J. E., Krueger, J. G., & Russell, C. B. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.194 · Cited by 466
“In contrast to the low fungal burdens in mice lacking IL-12 or IL-22, IL-17RA-deficient mice are more susceptible to Candida albicans infections (Huang et al., 2004; Kagami et al., 2010a), potentially due to neutrophil and AMP defects (Conti et al.”
Lin, L., Ibrahim, A. S., Xu, X., Farber, J. M., Avanesian, V., Baquir, B., Fu, Y., French, S. W., Edwards, J. E., & Spellberg, B. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000703 · Cited by 465
“albicans [41].”
Robinson, M. J., Osorio, F., Rosas, M., Freitas, R. P., Schweighoffer, E., Groß, O., Verbeek, J. S., Ruland, J., Tybulewicz, V., Brown, G. D., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082818 · Cited by 462
“This is in agreement with earlier observations that IL-17RA–deficient mice are very susceptible to the organism (Huang et al., 2004).”
ResultPathogenesis of psoriasis and development of treatment
Ogawa, E., Sato, Y., Minagawa, A., & Okuyama, R. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14139 · Cited by 456
The IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
T cell responses: naïve to memory and everything in between
Pennock, N. D., White, J. T., Cross, E. W., Cheney, E. E., Tamburini, B. A., & Kedl, R. M. (2013) · Advances in Physiology Education · doi:10.1152/advan.00066.2013 · Cited by 461
“In response to extracellular bacteria and fungi (34), innate immune cells generate large amounts of both TGF- and IL-6 (39).”
BackgroundMonoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice
Elson, C. O., Cong, Y., Weaver, C. T., Schoeb, T. R., McClanahan, T. K., Fick, R. B., & Kastelein, R. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.104 · Cited by 453
Th17 cells: Effector T cells with inflammatory properties
Korn, T., Oukka, M., Kuchroo, V., & Bettelli, E. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.007 · Cited by 445
“IL-17 receptor deficient mice are very susceptible to systemic infection with Candida albicans and eventually succumb to the pathogen since they cannot clear it [60].”
BackgroundMutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells
de Beaucoudrey, L., Puel, A., Filipe-Santos, O., Cobat, A., Ghandil, P., Chrabieh, M., Feinberg, J., von Bernuth, H., Samarina, A., Jannière, L., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080321 · Cited by 439
Immune activation and HIV persistence: implications for curative approaches to HIV infection
Klatt, N. R., Chomont, N., Douek, D. C., & Deeks, S. G. (2013) · Immunological Reviews · doi:10.1111/imr.12065 · Cited by 435
IL-17 disrupts corneal barrier following desiccating stress
De Paiva, C. S., Chotikavanich, S., Pangelinan, S. B., Pitcher, J. D., Fang, B., Zheng, X., Ma, P., Farley, W. J., Siemasko, K. F., Niederkorn, J. Y., et al. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.5 · Cited by 422
Essential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the Lung
Okamoto Yoshida, Y., Umemura, M., Yahagi, A., O’Brien, R. L., Ikuta, K., Kishihara, K., Hara, H., Nakae, S., Iwakura, Y., & Matsuzaki, G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903332 · Cited by 421
Innate Antifungal Immunity: The Key Role of Phagocytes
Brown, G. D. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101229 · Cited by 419
Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries
de Beaucoudrey, L., Samarina, A., Bustamante, J., Cobat, A., Boisson-Dupuis, S., Feinberg, J., Al-Muhsen, S., Jannière, L., Rose, Y., de Suremain, M., et al. (2010) · Medicine · doi:10.1097/md.0b013e3181fdd832 · Cited by 394
“Mice with impaired IL-17 immunity are susceptible to Candida.12,31,38 It has been demonstrated that patients with IL-12RA1 deficiency display impaired development of IL-17producing T cells, although this impairment is less pronounced than that in STAT3-deficient patients.14 The high proportion of patients with candidi…”
BackgroundTc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge
Hamada, H., Garcia-Hernandez, M. D. L. L., Reome, J. B., Misra, S. K., Strutt, T. M., McKinstry, K. K., Cooper, A. M., Swain, S. L., & Dutton, R. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801814 · Cited by 387
“The Th17 T cells represent a newly discovered subset of IL-17secreting CD4 T cells (15–19) that has been implicated in exacerbating autoimmune responses (20, 21) and also participating in enhancing beneficial Th1 responses in tuberculosis (22, 23) rota virus (24), Klebsiella pneumoniae (25), and Candida albicans infec…”
BackgroundInduction, function and regulation of IL‐17‐producing T cells
Mills, K. H. G. (2008) · European Journal of Immunology · doi:10.1002/eji.200838535 · Cited by 385
An overview of IL-17 function and signaling
Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.017 · Cited by 382
Jandus, C., Bioley, G., Rivals, J., Dudler, J., Speiser, D., & Romero, P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23655 · Cited by 382
Myeloid C-type Lectin Receptors in Pathogen Recognition and Host Defense
Osorio, F., & Reis e Sousa, C. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.001 · Cited by 378
Yu, J. J., Ruddy, M. J., Wong, G. C., Sfintescu, C., Baker, P. J., Smith, J. B., Evans, R. T., & Gaffen, S. L. (2007) · Blood · doi:10.1182/blood-2005-09-010116 · Cited by 372
Intricacies of TGF-β signaling in Treg and Th17 cell biology
Wang, J., Zhao, X., & Wan, Y. Y. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-01036-7 · Cited by 356
Griffin, G. K., Newton, G., Tarrio, M. L., Bu, D.-X., Maganto-Garcia, E., Azcutia, V., Alcaide, P., Grabie, N., Luscinskas, F. W., Croce, K. J., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200385 · Cited by 364
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Schinocca, C., Rizzo, C., Fasano, S., Grasso, G., La Barbera, L., Ciccia, F., & Guggino, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637829 · Cited by 360
Cytokine-mediated regulation of antimicrobial proteins
Kolls, J. K., McCray, P. B., & Chan, Y. R. (2008) · Nature Reviews Immunology · doi:10.1038/nri2433 · Cited by 363
Th17 cells in immunity to Candida albicans
Hernández-Santos, N., & Gaffen, S. L. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.04.008 · Cited by 361
“It is estimated that 1.5 million fungal species populate the planet, but only a few hundred establish infection in humans, and an even smaller number reside as commensals (Hube, 2009).”
InfluentialHamada, S., Umemura, M., Shiono, T., Tanaka, K., Yahagi, A., Begum, M. D., Oshiro, K., Okamoto, Y., Watanabe, H., Kawakami, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3456 · Cited by 353
“Candida albicans-infected IL-17A receptor-deficient mice also showed decreased survival and increased fungal burden from day 3 after the infection (6).”
BackgroundAlcorn, J. F., Crowe, C. R., & Kolls, J. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135926 · Cited by 348
The Macrophage Mannose Receptor Induces IL-17 in Response to Candida albicans
van de Veerdonk, F. L., Marijnissen, R. J., Kullberg, B. J., Koenen, H. J. P. M., Cheng, S.-C., Joosten, I., van den Berg, W. B., Williams, D. L., van der Meer, J. W. M., Joosten, L. A. B., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.02.006 · Cited by 339
Renner, E. D., Rylaarsdam, S., Aňover-Sombke, S., Rack, A. L., Reichenbach, J., Carey, J. C., Zhu, Q., Jansson, A. F., Barboza, J., Schimke, L. F., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.04.037 · Cited by 338
Interleukin‐23: as a drug target for autoimmune inflammatory diseases
Tang, C., Chen, S., Qian, H., & Huang, W. (2012) · Immunology · doi:10.1111/j.1365-2567.2011.03522.x · Cited by 337
Self-citationMutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome
Woellner, C., Gertz, E. M., Schäffer, A. A., Lagos, M., Perro, M., Glocker, E.-O., Pietrogrande, M. C., Cossu, F., Franco, J. L., Matamoros, N., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.059 · Cited by 316
Early and nonreversible decrease of CD161++/MAIT cells in HIV infection
Cosgrove, C., Ussher, J. E., Rauch, A., Gärtner, K., Kurioka, A., Hühn, M. H., Adelmann, K., Kang, Y.-H., Fergusson, J. R., Simmonds, P., et al. (2013) · Blood · doi:10.1182/blood-2012-06-436436 · Cited by 316
Th17 cells and mucosal host defense
Aujla, S. J., Dubin, P. J., & Kolls, J. K. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.009 · Cited by 304
IL-17–Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
Conti, H. R., & Gaffen, S. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500909 · Cited by 301
“Although systemic candidiasis has an IL-17 component, IFN-g from Th1 and NK cells seems to play a relatively more important role (1, 20).”
BackgroundSkin-resident T cells: the ups and downs of on site immunity
Clark, R. A. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.247 · Cited by 298
“…immunity against a variety of extracellular pathogens, including bacteria such as Klebsiella pneumoniae 364 Journal of Investigative Dermatology (2010), Volume 130 and fungi such as Cryptococcus neoformans and Candida albicans (Huang et al., 2004; Happel et al., 2005; Kleinschek et al., 2006).”
BackgroundIdentification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes
Shen, F., Hu, Z., Goswami, J., & Gaffen, S. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604597200 · Cited by 294
Pattern recognition: recent insights from Dectin-1
Reid, D. M., Gow, N. A., & Brown, G. D. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.003 · Cited by 289
“Why Dectin-1 actually promotes Th17 responses, in particular, is unclear, as these responses are thought to be detrimental during fungal infections [32], although this is still somewhat controversial [33,34].”
BackgroundRecent advances in the IL-17 cytokine family
Gaffen, S. L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.006 · Cited by 283
“In mice, deficiency of IL17A and IL-17RA but not IL-17F causes increased susceptibility to disseminated candidiasis [41,42].”
Pappu, R., Ramirez-Carrozzi, V., & Sambandam, A. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03465.x · Cited by 281
Th17 Cells in Immunity and Autoimmunity
Bedoya, S. K., Lam, B., Lau, K., & Larkin, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/986789 · Cited by 282
Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells
Gerosa, F., Baldani-Guerra, B., Lyakh, L. A., Batoni, G., Esin, S., Winkler-Pickett, R. T., Consolaro, M. R., De Marchi, M., Giachino, D., Robbiano, A., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071450 · Cited by 280
DC activated via dectin‐1 convert Treg into IL‐17 producers
Osorio, F., LeibundGut‐Landmann, S., Lochner, M., Lahl, K., Sparwasser, T., Eberl, G., & Reis e Sousa, C. (2008) · European Journal of Immunology · doi:10.1002/eji.200838950 · Cited by 273
Th17 T cells: Linking innate and adaptive immunity
Stockinger, B., Veldhoen, M., & Martin, B. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.008 · Cited by 271
Th17 cells in inflammation and autoimmunity
Singh, R. P., Hasan, S., Sharma, S., Nagra, S., Yamaguchi, D. T., Wong, D. T. W., Hahn, B. H., & Hossain, A. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.019 · Cited by 266
Development and function of TH17 cells in health and disease
Louten, J., Boniface, K., & de Waal Malefyt, R. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.04.003 · Cited by 266
“For instance, mice deficient in IL-17 or IL-17 receptor (IL-17R) A are susceptible to pulmonary infection with the extracellular pathogen Klebsiella pneumoniae,(42) and similarly, IL-17RA–deficient mice are greatly susceptible to Candida albicans.(43) TH17 cells are not the sole producers of IL-17, but the susceptibil…”
BackgroundIL-22 defines a novel immune pathway of antifungal resistance
De Luca, A., Zelante, T., D'Angelo, C., Zagarella, S., Fallarino, F., Spreca, A., Iannitti, R. G., Bonifazi, P., Renauld, J.-C., Bistoni, F., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.22 · Cited by 265
IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani
Pitta, M. G. R., Romano, A., Cabantous, S., Henri, S., Hammad, A., Kouriba, B., Argiro, L., el Kheir, M., Bucheton, B., Mary, C., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38813 · Cited by 265
Immune defence to invasive fungal infections: A comprehensive review
Pathakumari, B., Liang, G., & Liu, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110550 · Cited by 264
Schuetz, A., Deleage, C., Sereti, I., Rerknimitr, R., Phanuphak, N., Phuang-Ngern, Y., Estes, J. D., Sandler, N. G., Sukhumvittaya, S., Marovich, M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004543 · Cited by 262
“Recent studies have demonstrated the importance of IL-22 expressing CD4+T cells (Th22) contributing to the homeostasis of mucosal epithelial surfaces [19,20].”
BackgroundInterleukin‐17 as an Effector Molecule of Innate and Acquired Immunity against Infections
Matsuzaki, G., & Umemura, M. (2007) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2007.tb04008.x · Cited by 258
IL-17 contributes to CD4-mediated graft-versus-host disease
Kappel, L. W., Goldberg, G. L., King, C. G., Suh, D. Y., Smith, O. M., Ligh, C., Holland, A. M., Grubin, J., Mark, N. M., Liu, C., et al. (2009) · Blood · doi:10.1182/blood-2008-08-172155 · Cited by 256
Interplay between Candida albicans and the mammalian innate host defense
Cheng, S.-C., Joosten, L. A. B., Kullberg, B.-J., & Netea, M. G. (2012) · Infection and Immunity · doi:10.1128/iai.06146-11 · Cited by 256
“Several studies, though not all, have shown that mice deficient in IL-17 or the IL-17 receptor are more susceptible to systemic (45) or mucosal (22) Candida infection.”
BackgroundTh1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis
Yamada, H., Nakashima, Y., Okazaki, K., Mawatari, T., Fukushi, J.-I., Kaibara, N., Hori, A., Iwamoto, Y., & Yoshikai, Y. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.080341 · Cited by 251
The role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 248
Th17 cytokines and mucosal immunity
Dubin, P. J., & Kolls, J. K. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00703.x · Cited by 244
Metadata
- Authors
- Huang, W., Na, L., Fidel, P. L., & Schwarzenberger, P.
- Affiliations
- Louisiana State University Health Sciences Center New Orleans (US)
- Corresponding author
- Huang, Weitao
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08
- Volume
- 190
- Issue
- 3
- Pages
- 624-631
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2112133235
- Cited by
- 859
- References
- 30
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 25 · 2023: 21 · 2022: 20 · 2021: 23 · 2020: 19 · 2019: 23 · 2018: 28 · 2017: 35 · 2016: 41 · 2015: 53 · 2014: 48 · 2013: 52 · 2012: 74
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA081125)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17A, IL-17 receptor, Candida albicans, systemic candidiasis, neutrophil recruitment, T cell-dependent immunity, immunocompromised patients
- MeSH terms
- Animals, Candida albicans, Candidiasis, Disease Models, Animal, Humans, Kidney, Mice, Inbred C57BL, Recombinant Proteins, Receptors, Interleukin, Mice, Knockout, Interleukin-17, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.